UnitedHealth Q1 Disappoints, But These Analysts Remain Bullish On The Stock

Though UnitedHealth reported disappointing first-quarter results last week, two analysts from KeyBanc Capital Markets and Truist Securities remain bullish on the stock.  Latest Ratings for UNH Date Firm Action From To Jan 2022 SVB Leerink Maintains Outperform Jan 2022 BMO Capital Maintains Market Perform Jan 2022 Raymond James Maintains Strong Buy View More Analyst Ratings…

Read More